An Update on the Treatment of Papillary Renal Cell Carcinoma
Papillary renal cell carcinoma (pRCC) is the second-most common subtype of kidney cancer following clear cell renal cell carcinoma (ccRCC), representing 15% of kidney cancers. Despite advances in therapy, including combination strategies with targeted therapies and immune checkpoint inhibitors, prog...
Main Authors: | Neal S. Chawla, Nicolas Sayegh, Sweta Prajapati, Elyse Chan, Sumanta K. Pal, Alexander Chehrazi-Raffle |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/3/565 |
Similar Items
-
Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles
by: Ameish Govindarajan, et al.
Published: (2023-08-01) -
Clear cell and papillary renal cell carcinomas in hereditary papillary renal cell carcinoma (HPRCC) syndrome: a case report
by: Sophie Ferlicot, et al.
Published: (2021-11-01) -
Papillary renal cell carcinoma with malakoplakia: A unique case
by: Abigail A. Roth, et al.
Published: (2022-11-01) -
Immunohistochemical Analysis of Renal Solid and Papillary-Ductal Carcinoma in Dogs
by: Rafał Ciaputa, et al.
Published: (2014-10-01) -
Report of a Rare Case of Papillary Thyroid Carcinoma Associated with Renal Cell Carcinoma
by: Shivs Borzouei, et al.
Published: (2012-12-01)